Total Funding
14
Total FundingSeed raised
Growth Score
pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Kylin Therapeutics is a biotechnology company developing RNA interference-based therapeutics.
About the Company
Kylin Therapeutics, a biotechnology company, employs an RNA nanoparticle technology platform called “pRNA“ to exploit the enormous potential of RNA interference (RNAi) for treatment of many common diseases. The platform has enormous potential to meet the huge market opportunity for treating cancer and other diseases with RNA-based therapeutics.
The unique capabilities of the platform have enabled Kylin to overcome many challenges in the development of RNA-based therapies.
